Related Experiment Video
Updated: Nov 17, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Early Warning Factors of Death in COVID-19 Patients
Min Shang1, Jie Wei2,3, Han-Dong Zou2,3
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Insights
Early detection of COVID-19 mortality risk is crucial. Higher IL-6, lactate, older age, and lower lymphocyte counts at admission are key indicators for predicting in-hospital death in COVID-19 patients.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Biomarkers
Background:
- The global spread and evolution of COVID-19 have led to a rapid increase in mortality.
- Early identification of factors predicting mortality in COVID-19 patients remains a critical challenge for clinicians.
- Understanding these factors is essential for timely intervention and improved patient outcomes.
Purpose of the Study:
- To identify early warning factors associated with in-hospital mortality in COVID-19 patients.
- To evaluate the predictive performance of identified factors using statistical models and ROC curve analysis.
- To aid clinicians in identifying high-risk patients for prompt management.
Main Methods:
- Retrospective, single-center cohort study of adult inpatients with laboratory-confirmed COVID-19.
- Data extraction included demographic, clinical, and laboratory parameters at admission.
- Univariable analysis, Cox proportional hazards model, and ROC curve analysis were employed to identify risk factors.
Main Results:
- Hypertension and coronary heart disease were more prevalent in non-survivors.
- Symptoms like dyspnea, chest distress, and fatigue were significantly higher in non-survivors.
- Higher IL-6, lactate, older age, and lower lymphocyte counts at admission were associated with increased odds of in-hospital death.
Conclusions:
- Elevated IL-6, lactate, advanced age, and lymphopenia at admission are significant predictors of poor prognosis in COVID-19 patients.
- IL-6 and lymphocyte counts demonstrated high predictive accuracy for mortality.
- These findings can assist clinicians in early risk stratification and management of COVID-19 patients.
Abstract:
The infectious coronavirus disease 2019 (COVID-19) has spread all over the world and been persistently evolving so far. The number of deaths in the whole world has been rising rapidly. However, the early warning factors for mortality have not been well ascertained. In this retrospective, single-centre cohort study, we included some adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Renmin Hospital of Wuhan University who had been discharged or had died by Apr. 8, 2020. Demographic, clinical and laboratory data at admission were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable analysis, Cox proportional hazard model analysis and receiver operating characteristic (ROC) curve to explore the early warning factors associated with in-hospital death. A total of 159 patients were included in this study, of whom 86 were discharged and 73 died in hospital. Hypertension (52.1% vs. 29.1%, P=0.003) and coronary heart disease (28.8% vs. 12.8%, P=0.012) were more frequent among non-survived patients than among survived patients. The proportions of patients with dyspnoea (67.1% vs. 25.6%, P<0.001), chest distress (58.9% vs. 26.7%, P<0.001) and fatigue (64.4% vs. 25.6%, P<0.001) were significantly higher in the non-survived group than in the survived group. Regression analysis with the Cox proportional hazards mode revealed that increasing odds of in-hospital death were associated with higher IL-6 (odds ratio 10.87, 95% CI 1.41-83.59; P=0.022), lactate (3.59, 1.71-7.54; P=0.001), older age (1.86, 1.03-3.38; P=0.041) and lower lymphopenia (5.44, 2.71-10.93; P<0.001) at admission. The areas under the ROC curve (AUCs) of IL-6, lymphocyte, age and lactate were 0.933, 0.928, 0.786 and 0.753 respectively. The AUC of IL-6 was significantly higher than that of age (z=3.332, P=0.0009) and lactate (z=4.441, P<0.0001) for outcome prediction. There was no significant difference between the AUCs of IL-6 and lymphocyte for outcome prediction (z=0.372, P=0.7101). It was concluded that the potential risk factors of higher IL-6, lactate, older age and lower lymphopenia at admission could help clinicians to identify patients with poor prognosis at an early stage.
Related Concept Videos
Acute Respiratory Failure-IV
Coronary Artery Disease III: Clinical Manifestations
Pulmonary Embolism I: Introduction
Acute Respiratory Failure-III
Heart Failure III: Clinical Manifestations
Pneumonia III: Complications and Assessment

